Singapore markets closed

Straits Times Index
3,292.93
-3.96(-0.12%)
Nikkei
38,236.07
-37.98(-0.10%)
Hang Seng
18,475.92
+268.79(+1.48%)
FTSE 100
8,213.49
+41.34(+0.51%)
Bitcoin USD
62,834.94
+3,068.82(+5.13%)
CMC Crypto 200
1,359.39
+82.41(+6.45%)

Rocket Pharmaceuticals, Inc. (RCKT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

23.47

+0.70

(+3.07%)

At close: 04:00PM EDT

23.47

0.00

(0.00%)

After hours:

04:20PM EDT

Loading interactive chart…

Zacks
Rocket Pharmaceuticals (RCKT) Upgraded to Buy: Here's Why
Rocket Pharmaceuticals (RCKT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Insider Monkey
Should You Retain Your Conviction in Rocket Pharmaceuticals (RCKT)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]
Zacks
EMA Accepts Rocket (RCKT) Gene Therapy Filing for Fanconi Anemia
The EMA accepts Rocket's (RCKT) regulatory submission seeking approval for RP-L102, a gene therapy for a rare genetic disorder called fanconi anemia that affects the bone marrow.